Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Related Citations for PubMed (Select 24217424)

1.

Ribavirin protects Syrian hamsters against lethal hantavirus pulmonary syndrome--after intranasal exposure to Andes virus.

Ogg M, Jonsson CB, Camp JV, Hooper JW.

Viruses. 2013 Nov 8;5(11):2704-20. doi: 10.3390/v5112704.

2.

In vitro and in vivo activity of ribavirin against Andes virus infection.

Safronetz D, Haddock E, Feldmann F, Ebihara H, Feldmann H.

PLoS One. 2011;6(8):e23560. doi: 10.1371/journal.pone.0023560. Epub 2011 Aug 10.

3.

DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS).

Brocato R, Josleyn M, Ballantyne J, Vial P, Hooper JW.

PLoS One. 2012;7(4):e35996. doi: 10.1371/journal.pone.0035996. Epub 2012 Apr 27.

4.

Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine.

Custer DM, Thompson E, Schmaljohn CS, Ksiazek TG, Hooper JW.

J Virol. 2003 Sep;77(18):9894-905.

5.

A lethal disease model for hantavirus pulmonary syndrome in immunosuppressed Syrian hamsters infected with Sin Nombre virus.

Brocato RL, Hammerbeck CD, Bell TM, Wells JB, Queen LA, Hooper JW.

J Virol. 2014 Jan;88(2):811-9. doi: 10.1128/JVI.02906-13. Epub 2013 Nov 6.

6.

Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus.

Hooper JW, Ferro AM, Wahl-Jensen V.

J Virol. 2008 Feb;82(3):1332-8. Epub 2007 Nov 21.

7.

A lethal disease model for hantavirus pulmonary syndrome.

Hooper JW, Larsen T, Custer DM, Schmaljohn CS.

Virology. 2001 Oct 10;289(1):6-14.

8.

Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.

Brown KS, Safronetz D, Marzi A, Ebihara H, Feldmann H.

J Virol. 2011 Dec;85(23):12781-91. doi: 10.1128/JVI.00794-11. Epub 2011 Sep 14.

9.

Antiviral efficacy of favipiravir against two prominent etiological agents of hantavirus pulmonary syndrome.

Safronetz D, Falzarano D, Scott DP, Furuta Y, Feldmann H, Gowen BB.

Antimicrob Agents Chemother. 2013 Oct;57(10):4673-80. doi: 10.1128/AAC.00886-13. Epub 2013 Jul 15.

10.

T cells are not required for pathogenesis in the Syrian hamster model of hantavirus pulmonary syndrome.

Hammerbeck CD, Hooper JW.

J Virol. 2011 Oct;85(19):9929-44. doi: 10.1128/JVI.05356-11. Epub 2011 Jul 20. Erratum in: J Virol. 2012 Apr;86(7):4043.

11.

Hantavirus pulmonary syndrome.

Macneil A, Nichol ST, Spiropoulou CF.

Virus Res. 2011 Dec;162(1-2):138-47. doi: 10.1016/j.virusres.2011.09.017. Epub 2011 Sep 17. Review.

PMID:
21945215
12.

Andes virus M genome segment is not sufficient to confer the virulence associated with Andes virus in Syrian hamsters.

McElroy AK, Smith JM, Hooper JW, Schmaljohn CS.

Virology. 2004 Aug 15;326(1):130-9.

PMID:
15262501
13.

The Syrian hamster model of hantavirus pulmonary syndrome.

Safronetz D, Ebihara H, Feldmann H, Hooper JW.

Antiviral Res. 2012 Sep;95(3):282-92. doi: 10.1016/j.antiviral.2012.06.002. Epub 2012 Jun 15. Review.

14.

Pathogenesis and host response in Syrian hamsters following intranasal infection with Andes virus.

Safronetz D, Zivcec M, Lacasse R, Feldmann F, Rosenke R, Long D, Haddock E, Brining D, Gardner D, Feldmann H, Ebihara H.

PLoS Pathog. 2011 Dec;7(12):e1002426. doi: 10.1371/journal.ppat.1002426. Epub 2011 Dec 15.

15.

A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).

Hooper JW, Josleyn M, Ballantyne J, Brocato R.

Vaccine. 2013 Sep 13;31(40):4314-21. doi: 10.1016/j.vaccine.2013.07.025. Epub 2013 Jul 24.

16.

Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters.

Wahl-Jensen V, Chapman J, Asher L, Fisher R, Zimmerman M, Larsen T, Hooper JW.

J Virol. 2007 Jul;81(14):7449-62. Epub 2007 May 2.

17.

Induction of protective immunity in a Syrian hamster model against a cytopathogenic strain of Andes virus.

Martinez VP, Padula PJ.

J Med Virol. 2012 Jan;84(1):87-95. doi: 10.1002/jmv.22228.

PMID:
22095538
18.

Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group.

Chapman LE, Mertz GJ, Peters CJ, Jolson HM, Khan AS, Ksiazek TG, Koster FT, Baum KF, Rollin PE, Pavia AT, Holman RC, Christenson JC, Rubin PJ, Behrman RE, Bell LJ, Simpson GL, Sadek RF.

Antivir Ther. 1999;4(4):211-9.

PMID:
10723500
19.

Treatment of hantavirus pulmonary syndrome.

Jonsson CB, Hooper J, Mertz G.

Antiviral Res. 2008 Apr;78(1):162-9. Epub 2007 Nov 21. Review.

20.

Andes virus recognition of human and Syrian hamster beta3 integrins is determined by an L33P substitution in the PSI domain.

Matthys VS, Gorbunova EE, Gavrilovskaya IN, Mackow ER.

J Virol. 2010 Jan;84(1):352-60. doi: 10.1128/JVI.01013-09. Epub .

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk